HOME › DRUGS › ALOGLIPTIN BENZOATE
ACTIVE SUBSTANCE / INN

ALOGLIPTIN BENZOATE

Brand name(s): ALOGLIPTIN, KAZANO, Vipidia, OSENI, NESINA
FDA LISTED
EMA LISTED
PRESCRIPTION
DISCONTINUED
AUTHORISED
ANDA210002
NDA022426
ACTIVE SUBSTANCE
Alogliptin Benzoate
REGULATORS
FDA · EMA
SPONSORS / MAH
TAKEDA PHARMS USA, Takeda Pharma A/S, INDOCO REMEDIES
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KAZANONDA203414TAKEDA PHARMS USAPrescription
NESINANDA022271TAKEDA PHARMS USAPrescription
ALOGLIPTINANDA210002INDOCO REMEDIESNone (Tentative Approval)
OSENINDA022426TAKEDA PHARMS USADiscontinued
OSENINDA022426TAKEDA PHARMS USAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
VipidiaTakeda Pharma A/SAuthorised18/09/2013Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON ALOGLIPTIN BENZOATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →